Literature DB >> 19218236

Inhibition of SUV39H1 methyltransferase activity by DBC1.

Zhenyu Li1, Lihong Chen, Neha Kabra, Chuangui Wang, Jia Fang, Jiandong Chen.   

Abstract

SUV39H1 is a histone H3K9-specific methyltransferase important for heterochromatin formation, regulation of gene expression, and induction of senescence in premalignant cells. SUV39H1 forms a complex with SirT1, and its activity is stimulated by SirT1 binding. Here we present evidence that the product of the DBC1 (deleted in breast cancer 1) gene disrupts the SUV39H1-SirT1 complex. Furthermore, DBC1 binds to the SUV39H1 catalytic domain and inhibits its ability to methylate histone H3 in vitro and in vivo. Knockdown of endogenous DBC1 increased the level of cellular H3K9 methylation. As expected, DBC1 also binds to SirT1 and inhibits the deacetylase activity of SirT1. These results identify DBC1 as a novel cellular inhibitor of SUV39H1 activity. DBC1 may be an important regulator of heterochromatin formation and genomic stability by disrupting the SUV39H1-SirT1 complex and inactivating both enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218236      PMCID: PMC2667723          DOI: 10.1074/jbc.M900956200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase.

Authors:  L Vandel; E Nicolas; O Vaute; R Ferreira; S Ait-Si-Ali; D Trouche
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  Rb targets histone H3 methylation and HP1 to promoters.

Authors:  S J Nielsen; R Schneider; U M Bauer; A J Bannister; A Morrison; D O'Carroll; R Firestein; M Cleary; T Jenuwein; R E Herrera; T Kouzarides
Journal:  Nature       Date:  2001-08-02       Impact factor: 49.962

3.  Negative control of p53 by Sir2alpha promotes cell survival under stress.

Authors:  J Luo; A Y Nikolaev; S Imai; D Chen; F Su; A Shiloh; L Guarente; W Gu
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

4.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

5.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Authors:  S Imai; C M Armstrong; M Kaeberlein; L Guarente
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

6.  Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability.

Authors:  A H Peters; D O'Carroll; H Scherthan; K Mechtler; S Sauer; C Schöfer; K Weipoltshammer; M Pagani; M Lachner; A Kohlmaier; S Opravil; M Doyle; M Sibilia; T Jenuwein
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

7.  DBC1 is a negative regulator of SIRT1.

Authors:  Ja-Eun Kim; Junjie Chen; Zhenkun Lou
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

8.  Negative regulation of the deacetylase SIRT1 by DBC1.

Authors:  Wenhui Zhao; Jan-Philipp Kruse; Yi Tang; Sung Yun Jung; Jun Qin; Wei Gu
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

9.  Epigenetic control of rDNA loci in response to intracellular energy status.

Authors:  Akiko Murayama; Kazuji Ohmori; Akiko Fujimura; Hiroshi Minami; Kayoko Yasuzawa-Tanaka; Takao Kuroda; Shohei Oie; Hiroaki Daitoku; Mitsuru Okuwaki; Kyosuke Nagata; Akiyoshi Fukamizu; Keiji Kimura; Toshiyuki Shimizu; Junn Yanagisawa
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

10.  The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.

Authors:  Ron Firestein; Gil Blander; Shaday Michan; Philipp Oberdoerffer; Shuji Ogino; Jennifer Campbell; Anupama Bhimavarapu; Sandra Luikenhuis; Rafael de Cabo; Charles Fuchs; William C Hahn; Leonard P Guarente; David A Sinclair
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

View more
  46 in total

1.  DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.

Authors:  Sinyi Kong; Muthusamy Thiruppathi; Quan Qiu; Zhenghong Lin; Hongxin Dong; Eduardo N Chini; Bellur S Prabhakar; Deyu Fang
Journal:  J Immunol       Date:  2014-10-31       Impact factor: 5.422

2.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

3.  HDAC3 is negatively regulated by the nuclear protein DBC1.

Authors:  Claudia C S Chini; Carlos Escande; Veronica Nin; Eduardo N Chini
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

Review 4.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

Review 5.  SIRT1 and p53, effect on cancer, senescence and beyond.

Authors:  Jingjie Yi; Jianyuan Luo
Journal:  Biochim Biophys Acta       Date:  2010-05-13

6.  hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.

Authors:  Hong Zheng; Leixiang Yang; Lirong Peng; Victoria Izumi; John Koomen; Edward Seto; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

7.  The dual role of sirtuins in cancer.

Authors:  Laia Bosch-Presegué; Alejandro Vaquero
Journal:  Genes Cancer       Date:  2011-06

8.  Histone modifiers in cancer: friends or foes?

Authors:  Idan Cohen; Elżbieta Poręba; Kinga Kamieniarz; Robert Schneider
Journal:  Genes Cancer       Date:  2011-06

9.  Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.

Authors:  Sun Hee Park; Philip Riley; Steven M Frisch
Journal:  Apoptosis       Date:  2013-08       Impact factor: 4.677

10.  The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression.

Authors:  Sophie S B Giguère; Amanda J Guise; Pierre M Jean Beltran; Preeti M Joshi; Todd M Greco; Olivia L Quach; Jeffery Kong; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2015-12-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.